Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Tablets may appeal not just to new patients, but also to existing or previous injection users looking for a treatment option that feels easier to maintain
GLP-1 agonists such as Wegovy (semaglutide) and Zepbound (tirzepatide) have demonstrated up to 20% body weight reductions in pivotal trials an efficacy previously thought achievable only through bariatric surgery
These drugs are FDA-approved for type 2 diabetes and obesity, but growing evidence supports their use for rheumatoid arthritis, psoriatic arthritis, lupus, osteoarthritis, and metabolic/autoimmune diseases. Who should not take GLP-1 medications
2019 Sep;11(9):2073
US$ 27.35
US$ 20.81
US$ 29.00
US$ 26.78
US$ 23.48
US$ 24.77
US$ 21.37
US$ 27.46
US$ 26.35
US$ 23.89
US$ 27.19
US$ 24.30
